Search research articles
Contact Us
Filters
Showing results (1-10 of 6) with videos related to
Page
of 1
Sort By:
Environmetrics
|
June 26, 2020
Adaptive predictive principal components for modeling multivariate air pollution
Maitreyee Bose, Timothy Larson, Adam A Szpiro
Psychometrika
|
November 19, 2017
Detecting Multiple Random Changepoints in Bayesian Piecewise Growth Mixture Models
Eric F Lock, Nidhi Kohli, Maitreyee Bose
Biometrics
|
February 15, 2018
Toward a diagnostic toolkit for linear models with Gaussian-process distributed random effects
Maitreyee Bose, James S Hodges, Sudipto Banerjee
Clinical Pharmacokinetics
|
April 18, 2023
Mechanistic Pharmacokinetic/Pharmacodynamic Modeling in Support of a Patient-Convenient, Longer Dosing Interval for Carfilzomib, a Covalent Inhibitor of the Proteasome
Marc R Yago, Khamir Mehta, Maitreyee Bose, et al.
Journal of Clinical Pharmacology
|
August 6, 2025
Clinical Pharmacology Characterization and Dose Selection of Xaluritamig, a Next Generation XmAb® 2+1 T-Cell Engager, in Prostate Cancer Patients
Jamie N Kuipers-Connarn, Arya Pourzanjani, Maitreyee Bose, et al.
BMC Bioinformatics
|
September 21, 2014
Evaluation of microarray-based DNA methylation measurement using technical replicates: the Atherosclerosis Risk In Communities (ARIC) Study
Maitreyee Bose, Chong Wu, James S Pankow, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 6) with videos related to
Sort By:
Page
of 1
Environmetrics
|
June 26, 2020
Adaptive predictive principal components for modeling multivariate air pollution
Maitreyee Bose, Timothy Larson, Adam A Szpiro
Psychometrika
|
November 19, 2017
Detecting Multiple Random Changepoints in Bayesian Piecewise Growth Mixture Models
Eric F Lock, Nidhi Kohli, Maitreyee Bose
Biometrics
|
February 15, 2018
Toward a diagnostic toolkit for linear models with Gaussian-process distributed random effects
Maitreyee Bose, James S Hodges, Sudipto Banerjee
Clinical Pharmacokinetics
|
April 18, 2023
Mechanistic Pharmacokinetic/Pharmacodynamic Modeling in Support of a Patient-Convenient, Longer Dosing Interval for Carfilzomib, a Covalent Inhibitor of the Proteasome
Marc R Yago, Khamir Mehta, Maitreyee Bose, et al.
Journal of Clinical Pharmacology
|
August 6, 2025
Clinical Pharmacology Characterization and Dose Selection of Xaluritamig, a Next Generation XmAb® 2+1 T-Cell Engager, in Prostate Cancer Patients
Jamie N Kuipers-Connarn, Arya Pourzanjani, Maitreyee Bose, et al.
BMC Bioinformatics
|
September 21, 2014
Evaluation of microarray-based DNA methylation measurement using technical replicates: the Atherosclerosis Risk In Communities (ARIC) Study
Maitreyee Bose, Chong Wu, James S Pankow, et al.
Page
of 1